Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intestinal inflammation and the gut microflora.

D M McKay1

  • 1Intestinal Disease Research Programme, McMaster University, Hamilton, Canada. mckayd@fjs.McMaster.ca

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|August 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triggering immunological memory against the tapeworm Hymenolepis diminuta to protect against colitis.

Parasite immunology·2017
Same author

Suppression of colitis by adoptive transfer of helminth antigen-treated dendritic cells requires interleukin-4 receptor-α signaling.

Scientific reports·2017
Same author

Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.

Neurogastroenterology and motility·2013
Same author

In vitro anaerobic biofilms of human colonic microbiota.

Journal of microbiological methods·2010
Same author

Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice.

Infection and immunity·2009
Same author

Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors.

Neurogastroenterology and motility·2009

The gut microbiome significantly influences inflammatory bowel disease (IBD) development and progression. Research highlights how enteric bacteria and their products can trigger or worsen gut inflammation, supporting antibiotic therapy for IBD.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • The role of gut microflora in inflammatory bowel disease (IBD) pathogenesis is a long-standing area of research.
  • Interest in the connection between gut bacteria and functional bowel disorders, alongside antibiotic therapy for gut inflammation, has resurfaced.
  • Identifying an infectious cause for chronic IBD, especially Crohn's disease, has been a major research focus.

Purpose of the Study:

  • To review experimental and clinical evidence on the pivotal role of enteric bacteria in gut inflammation.
  • To illustrate how bacteria and their products can initiate or aggravate gut inflammation.

Main Methods:

  • Review of pertinent scientific literature.
  • Analysis of experimental evidence from laboratory models.

Related Experiment Videos

  • Examination of findings from clinical investigations.

    • Main Results:

    • Evidence supports a significant role for enteric bacteria in the pathophysiology of IBD.
    • Bacterial products are shown to be capable of evoking or exacerbating gut inflammation.
    • Studies illustrate the impact of gut microbiota on inflammatory processes.

    Conclusions:

    • Enteric bacteria are key players in the development and exacerbation of gut inflammation in IBD.
    • The findings underscore the potential therapeutic value of targeting the gut microbiome in IBD management.
    • Further research into the bacteria-host interactions in IBD is warranted.